Matches in Nanopublications for { ?s ?p "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP885956.RAoLDE2z1afvmGuSakKDpbBnuqRxrJ8Iig895BuFcbMPA130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885956.RAoLDE2z1afvmGuSakKDpbBnuqRxrJ8Iig895BuFcbMPA130_provenance.
- NP346767.RAgD1CT2nPiXFy3UWaIfbTxJxhsSVvU1k7eNohTfs2bnI130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346767.RAgD1CT2nPiXFy3UWaIfbTxJxhsSVvU1k7eNohTfs2bnI130_provenance.
- NP765612.RAAu75SxL6Pr0Cwbz9i6t9X2nDoPrIYxDUGuWvZJOUAFM130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765612.RAAu75SxL6Pr0Cwbz9i6t9X2nDoPrIYxDUGuWvZJOUAFM130_provenance.
- NP469927.RAe6GsiH8bV3Eu0oxvEzKCba2oyJcZhJc8XM_WwOed7ig130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469927.RAe6GsiH8bV3Eu0oxvEzKCba2oyJcZhJc8XM_WwOed7ig130_provenance.
- assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP796311.RAvq4AJ8dT_PwBIp1y84-XLawT93MX_h8W54zPTT17ibU130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796311.RAvq4AJ8dT_PwBIp1y84-XLawT93MX_h8W54zPTT17ibU130_provenance.
- NP796309.RAJdStiaSpNgeWlpVeVuqAuRPUGCrAZ4gF59U37XDTxyo130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796309.RAJdStiaSpNgeWlpVeVuqAuRPUGCrAZ4gF59U37XDTxyo130_provenance.